Cubist Systematic Strategies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
2024
Q2
$2.97M Buy
2024
Q1
$1.1M Sell
2023
Q4
$2.33M Buy
2023
Q1
Sell
2022
Q4
$192K Sell
2022
Q3
$938K Buy
2022
Q1
Sell
2021
Q4
$275K Sell
2021
Q3
$525K Buy
2021
Q2
$3K Sell
2021
Q1
$5K Sell
2020
Q4
$201K Buy